Overexpression of Candida albicans CDR1,CDR2, or MDR1 Does Not Produce Significant Changes in Echinocandin Susceptibility

Niimi, K.; Maki, K.; Ikeda, F.; Holmes, A. R.; Lamping, E.; Niimi, M.; Monk, B. C.; Cannon, R. D.

doi:10.1128/aac.50.4.1148-1155.2006

Cited by 135Antifungal resistance and susceptibilityFungal and yeast genetics researchDrug Transport and Resistance Mechanisms

Overexpression of Candida albicans CDR1,CDR2, or MDR1 Does Not Produce Significant Changes in Echinocandin Susceptibility

Open access

Niimi, K., Maki, K., Ikeda, F., Holmes, A. R., Lamping, E., Niimi, M., Monk, B. C., Cannon, R. D.·2006·Antimicrobial Agents and Chemotherapy

DOI 10.1128/aac.50.4.1148-1155.2006PMC PMC1426986

Open this paper in CoChat — free account

Abstract

The micafungin and caspofungin susceptibilities of Candida albicans laboratory and clinical isolates and of Saccharomyces cerevisiae strains stably hyperexpressing fungal ATP-binding cassette (ABC) or major facilitator superfamily (MFS) transporters involved in azole resistance were determined using three separate methods. Yeast strains hyperexpressing individual alleles of ABC transporters or an MFS transporter from C. albicans gave the expected resistance profiles for the azoles fluconazole, itraconazole, and voriconazole. The strains hyperexpressing CDR2 showed slightly decreased susceptibility to caspofungin in agar plate drug resistance assays, as previously reported, but increased susceptibility to micafungin compared with either the strains hyperexpressing CDR1 or the null parent deleted of seven ABC transporters. The strains hyperexpressing CDR1 showed slightly decreased susceptibility to micafungin in these assays. A C. albicans clinical isolate overexpressing both Cdr1p and Cdr2p relative to its azole-sensitive isogenic progenitor acquired resistance to azole drugs and showed reduced susceptibility to caspofungin and slightly increased susceptibility to micafungin in agar plate drug resistance assays. None of the strains showed significant resistance to micafungin or caspofungin in liquid microdilution susceptibility assays. The antifungal activities of micafungin and caspofungin were similar in agarose diffusion assays, although the shape and size of the caspofungin inhibitory zones were affected by medium composition. The assessment of micafungin and caspofungin potency is therefore assay dependent; the differences seen with agar plate drug resistance assays occur over narrow ranges of echinocandin concentrations and are not of clinical significance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/aac.50.4.1148-1155.2006

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Triazole-resistant clinical isolates and laboratory strains that demonstrate increased drug efflux pump expression remain susceptible to the echinocandins in laboratory liquid assays.
“Triazole-resistant clinical isolates (Pfaller et al., 2005; Messer et al., 2006) and laboratory strains (Niimi et al., 2006) that demonstrate increased drug efflux pump expression remain susceptible to the echinocandins in laboratory liquid assays.”
From Genetic Drivers of Multidrug Resistance in Candida glabrata (2016) · cites this paper as Niimi et al., 2006

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736 · see citing works
Well diffusion for antifungal susceptibility testing
Magaldi, S., Mata-Essayag, S., Hartung de Capriles, C., Perez, C., Colella, M. T., Olaizola, C., & Ontiveros, Y. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.03.002 · Cited by 927 · see citing works
The diploid genome sequence of Candida albicans
Jones, T., Federspiel, N. A., Chibana, H., Dungan, J. M., Kalman, S., Magee, B. B., Newport, G., Thorstenson, Y. R., Agabian, N. M., Magee, P. T., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401648101 · Cited by 768 · see citing works
Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates
Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434 · see citing works
TAC1 , Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2
Coste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407 · see citing works
In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi
Tawara, S., Ikeda, F., Maki, K., Morishita, Y., Otomo, K., Teratani, N., Goto, T., Tomishima, M., Ohki, H., Yamada, A., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.57-62.2000 · Cited by 311 · see citing works
Echinocandins: a new class of antifungal
Denning, D. W. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf045 · Cited by 300 · see citing works
Multiechinocandin- and Multiazole-ResistantCandida parapsilosisIsolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis
Moudgal, V. V., Little, T., Boikov, D. A., & Vázquez, J. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.767-769.2005 · Cited by 241 · see citing works
Paradoxical Effect of Caspofungin: Reduced Activity against Candida albicans at High Drug Concentrations
Stevens, D. A., Espiritu, M., & Parmar, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3407-3411.2004 · Cited by 218 · see citing works
Functional Expression of Candida albicans Drug Efflux Pump Cdr1p in a Saccharomyces cerevisiae Strain Deficient in Membrane Transporters
Nakamura, K., Niimi, M., Niimi, K., Holmes, A. R., Yates, J. E., Decottignies, A., Monk, B. C., Goffeau, A., & Cannon, R. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3366-3374.2001 · Cited by 185 · see citing works
Caspofungin Resistance inCandida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis
Hernandez, S., López-Ribot, J. L., Najvar, L. K., McCarthy, D. I., Bocanegra, R., & Graybill, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1382-1383.2004 · Cited by 162 · see citing works
In Vitro Activity of Micafungin (FK-463) against Candida spp.: Microdilution, Time-Kill, and Postantifungal-Effect Studies
Ernst, E. J., Roling, E. E., Petzold, C., Keele, D. J., & Klepser, M. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3846-3853.2002 · Cited by 156 · see citing works
In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant Isolates
Pfaller, M. A., Diekema, D. J., Messer, S. A., Hollis, R. J., & Jones, R. N. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1068-1071.2003 · Cited by 152 · see citing works
Caspofungin: the first in a new class of antifungal agents
Kartsonis, N. A., NIELSEN, J. B. K., & Douglas, C. M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00064-5 · Cited by 146 · see citing works
Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies
Kurtz, M., Abruzzo, G. K., Flattery, A. M., Bartizal, K. F., Marrinan, J. A., Li, W., Milligan, J. A., Nollstadt, K. H., & Douglas, C. M. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3244-3251.1996 · Cited by 136 · see citing works
A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase
Douglas, C. M., Marrinan, J. A., Li, W., & Kurtz, M. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.18.5686-5696.1994 · Cited by 129 · see citing works
The Candida Genome Database (CGD), a community resource for Candida albicans gene and protein information
Arnaud, M. B. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki003 · Cited by 124 · see citing works
In Vitro Activity of Caspofungin (MK-0991) against Candida albicans Clinical Isolates Displaying Different Mechanisms of Azole Resistance
Bachmann, S. P., Patterson, T. F., & Lopez-Ribot, J. L. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.2228-2230.2002 · Cited by 117 · see citing works
Chemosensitization of Fluconazole Resistance in Saccharomyces cerevisiae and Pathogenic Fungi by a d -Octapeptide Derivative
Niimi, K., Harding, D. R. K., Parshot, R., King, A., Lun, D. J., Decottignies, A., Niimi, M., Lin, S., Cannon, R. D., Goffeau, A., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1256-1271.2004 · Cited by 115 · see citing works
ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators
Smriti, S., Krishnamurthy, S., Dixit, B. L., Gupta, C. M., Milewski, S., & Prasad, R. (2002) · Yeast · doi:10.1002/yea.818 · Cited by 113 · see citing works
The Candida albicans Cdr2p ATP‐binding cassette (ABC) transporter confers resistance to caspofungin
Schuetzer‐Muehlbauer, M., Willinger, B., Krapf, G., Enzinger, S., Presterl, E., & Kuchler, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03430.x · Cited by 111 · see citing works
FK463, a Novel Water-soluble Echinocandin Lipopeptide. Synthesis and Antifungal Activity.
Tomishima, M., Ohki, H., Yamada, A., Takasugi, H., Maki, K., Tawara, S., & Tanaka, H. (1999) · The Journal of Antibiotics · doi:10.7164/antibiotics.52.674 · Cited by 107 · see citing works
Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicans
Marr, K. A., Lyons, C. N., Ha, K. C., Rustad, T. R., & White, T. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.52-59.2001 · Cited by 106 · see citing works
Drug resistance genes and trailing growth in Candida albicans isolates
Lee, M.-K. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh040 · Cited by 103 · see citing works
Further Standardization of Broth Microdilution Methodology for In Vitro Susceptibility Testing of Caspofungin against Candida Species by Use of an International Collection of More than 3,000 Clinical Isolates
Pfaller, M. A., Messer, S. A., Boyken, L. B., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.3117-3119.2004 · Cited by 90 · see citing works
In Vitro Antifungal Activity of a Novel Lipopeptide Antifungal Agent, FK463, Against Various Fungal Pathogens.
Uchida, K., NISHIYAMA, Y., Yokota, N., & YAMAGUCHI, H. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.1175 · Cited by 79 · see citing works
Surface-Active Fungicidal d -Peptide Inhibitors of the Plasma Membrane Proton Pump That Block Azole Resistance
Monk, B. C., Niimi, K., Lin, S. X., Knight, A., Kardos, T. B., Cannon, R. D., Parshot, R., King, A., Lun, D. J., & Harding, D. R. K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.57-70.2005 · Cited by 66 · see citing works
Candida glabrata ATP-binding Cassette Transporters Cdr1p and Pdh1p Expressed in aSaccharomyces cerevisiae Strain Deficient in Membrane Transporters Show Phosphorylation-dependent Pumping Properties
Wada, S.-I., Niimi, M., Niimi, K., Holmes, A. R., Monk, B. C., Cannon, R. D., & Uehara, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207817200 · Cited by 63 · see citing works
MovieMaker: a web server for rapid rendering of protein motions and interactions
Maiti, R., Domselaar, G. H. V., & Wishart, D. S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki485 · Cited by 62 · see citing works
Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatus
Bartizal, C., & Odds, F. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2100-2107.2003 · Cited by 60 · see citing works
Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients
Maebashi, K., Niimi, M., Kudoh, M., Fischer, F. J., Makimura, K., Niimi, K., Piper, R., Uchida, K., Arisawa, M., Cannon, R. D., et al. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.527 · Cited by 60 · see citing works
Comparison of Two Methods and Three End Points in Determination of In Vitro Activity of Micafungin against Aspergillus spp
Arıkan, S., Yurdakul, P., & Hasçelik, G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2640-2643.2003 · Cited by 55 · see citing works
Caspofungin Uptake Is Mediated by a High-Affinity Transporter in Candida albicans
Paderu, P., Park, S., & Perlin, D. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3845-3849.2004 · Cited by 49 · see citing works
Phosphorylation of Candida glabrata ATP-binding Cassette Transporter Cdr1p Regulates Drug Efflux Activity and ATPase Stability
Wada, S.-I., Tanabe, K., Yamazaki, A., Niimi, M., Uehara, Y., Niimi, K., Lamping, E., Cannon, R. D., & Monk, B. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408252200 · Cited by 39 · see citing works
Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole
Niimi, M., Nagai, Y., Niimi, K., Wada, S.-I., Cannon, R. D., Uehara, Y., & Monk, B. C. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00668-2 · Cited by 38 · see citing works
Functional Analysis of Fungal Drug Efflux Transporters by Heterologous Expression in Saccharomyces cerevisiae
Niimi, M., Wada, S.-I., Tanabe, K., Kaneko, A., Takano, Y., Umeyama, T., Hanaoka, N., Uehara, Y., Lamping, E., Niimi, K., et al. (2005) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2005.1 · Cited by 21 · see citing works
An Efficient System for Functional Hyper-expression of Multidrug Efflux Pumps in Saccharomyces cerevisiae
Niimi, M. (2004) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.45.63 · Cited by 3 · see citing works

Flagged first, then by citations

Research works printed but not linked: 1

[10]Ikeda, F., K. Otomo, T. Nakai, Y. Morishita, K. Maki, S. Tawara, S. Mutoh, F. Matsumoto, and S. Kuwahara. 2002. In vitro activity of a new lipopeptide antifungal agent, micafungin, against a variety of clinically important fungi. Jpn. J. Chemother. 50:8-19. [Google Scholar]

Sorted by citations

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · see citing works
The global problem of antifungal resistance: prevalence, mechanisms, and management
Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055 · see citing works
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647 · see citing works
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608 · see citing works
Fungal Biofilm Resistance
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583 · see citing works
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576 · see citing works
Resistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512 · see citing works
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422 · see citing works
Antifungal drug resistance among Candida species: mechanisms and clinical impact
Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394 · see citing works
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377 · see citing works
Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
Pfaller, M. A., Diekema, D. J., Andes, D. R., Arendrup, M. C., Brown, S. D., Lockhart, S. R., Motyl, M. R., & Perlin, D. S. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.004 · Cited by 335 · see citing works
Mechanisms of echinocandin antifungal drug resistance
Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313 · see citing works
The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
Cowen, L. E. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1835 · Cited by 311 · see citing works
Candida Species Biofilms’ Antifungal Resistance
Silva, S. M., Rodrigues, C. F., Araújo, D., Rodrigues, M. E., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 308 · see citing works
Regulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · see citing works
Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285 · see citing works
Current Perspectives on Echinocandin Class Drugs
Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.19 · Cited by 274 · see citing works
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271 · see citing works
Fungal echinocandin resistance
Walker, L. A., Gow, N. A. R., & Munro, C. A. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.09.003 · Cited by 267 · see citing works
Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints
Pfaller, M. A., Diekema, D. J., Ostrosky-Zeichner, L., Rex, J. H., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Ghannoum, M. A., Knapp, C. C., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00566-08 · Cited by 250 · see citing works
Efflux in Fungi: La Pièce de Résistance
Coleman, J. J., & Mylonakis, E. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000486 · Cited by 236 · see citing works
Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials
Hernando‐Amado, S., Blanco, P., Alcalde‐Rico, M., Corona, F., Reales‐Calderón, J. A., Sánchez, M. B., & Martínez, J. L. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.06.007 · Cited by 207 · see citing works
Candida albicans drug resistance—Another way to cope with stress
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Tanabe, K., Niimi, M., & Monk, B. C. (2007) · Microbiology · doi:10.1099/mic.0.2007/010405-0 · Cited by 208 · see citing works
The Echinocandins
Cappelletty, D., & Eiselstein‐McKitrick, K. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.369 · Cited by 205 · see citing works
Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 204 · see citing works
Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
Healey, K. R., & Perlin, D. S. (2018) · Journal of Fungi · doi:10.3390/jof4030105 · Cited by 194 · see citing works
Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression inSaccharomyces cerevisiae
Lamping, E., Monk, B. C., Niimi, K., Holmes, A. R., Tsao, S., Tanabe, K., Niimi, M., Uehara, Y., & Cannon, R. D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00091-07 · Cited by 192 · see citing works
Update on Antifungal Drug Resistance
Perlin, D. S., Shor, E., & Zhao, Y. (2015) · Current Clinical Microbiology Reports · doi:10.1007/s40588-015-0015-1 · Cited by 174 · see citing works
ABC Transporter Cdr1p Contributes More than Cdr2p Does to Fluconazole Efflux in Fluconazole-Resistant Candida albicans Clinical Isolates
Holmes, A. R., Lin, Y.-H., Niimi, K., Lamping, E., Keniya, M. V., Niimi, M., Tanabe, K., Monk, B. C., & Cannon, R. D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00463-08 · Cited by 160 · see citing works
Candida auris Genetics and Emergence
Chowdhary, A., Jain, K., & Chauhan, N. (2023) · Annual Review of Microbiology · doi:10.1146/annurev-micro-032521-015858 · Cited by 158 · see citing works
Targeting Efflux Pumps to Overcome Antifungal Drug Resistance
Holmes, A. R., Cardno, T. S., Strouse, J. J., Ivnitski-Steele, I., Keniya, M. V., Lackovic, K., Monk, B. C., Sklar, L. A., & Cannon, R. D. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0050 · Cited by 156 · see citing works
Echinocandins in antifungal pharmacotherapy
Patil, A., & Majumdar, S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12780 · Cited by 145 · see citing works
Mecanismos de resistencia a los antifúngicos: levaduras y hongos filamentosos
Espinel‐Ingroff, A. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70027-5 · Cited by 139 · see citing works
New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance
Fera, M. T., Camera, E. L., & Sarro, A. D. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.67 · Cited by 134 · see citing works
Responding to the Emergence of Antifungal Drug Resistance: Perspectives from the Bench and the Bedside
Beardsley, J., Halliday, C. L., Chen, S. C. ‐., & Sorrell, T. C. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0059 · Cited by 126 · see citing works
Antifungal drug resistance mechanisms
Pemán, J., Cantón, E., & Espinel‐Ingroff, A. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.18 · Cited by 121 · see citing works
Echinocandins: production and applications
Emri, T., Majoros, L., Tóth, V., & Pócsi, I. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-4761-9 · Cited by 110 · see citing works
The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates
Holmes, A. R., Keniya, M. V., Ivnitski-Steele, I., Monk, B. C., Lamping, E., Sklar, L. A., & Cannon, R. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05706-11 · Cited by 106 · see citing works
A Xenobiotic Detoxification Pathway through Transcriptional Regulation in Filamentous Fungi
Sang, H., Hulvey, J. P., Green, R., Xu, H., Im, J., Chang, T., & Jung, G. (2018) · mBio · doi:10.1128/mbio.00457-18 · Cited by 100 · see citing works
Review on Current Status of Echinocandins Use
Mroczyńska, M., & Brillowska‐Dąbrowska, A. (2020) · Antibiotics · doi:10.3390/antibiotics9050227 · Cited by 108 · see citing works
Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
Perlin, D. S. (2014) · Drugs · doi:10.1007/s40265-014-0286-5 · Cited by 99 · see citing works
Resistance to Antifungal Drugs
Ben‐Ami, R., & Kontoyiannis, D. P. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.003 · Cited by 101 · see citing works
Antifungal Resistance in Candida auris: Molecular Determinants
Frías-De-León, M. G., Hernández-Castro, R., Vite-Garín, T., Arenas, R., Bonifaz, A., Castañón-Olivares, L., Acosta-Altamirano, G., & Martínez-Herrera, E. (2020) · Antibiotics · doi:10.3390/antibiotics9090568 · Cited by 93 · see citing works
Genetic Drivers of Multidrug Resistance in Candida glabrata
Healey, K. R., Jimenez Ortigosa, C., Shor, E., & Perlin, D. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01995 · Cited by 93 · see citing works
Drug resistance mechanisms and their regulation in non- albicans Candida species
Kołaczkowska, A., & Kołaczkowski, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv445 · Cited by 88 · see citing works
Advances in Antifungal Therapy
Sable, C. A., Strohmaier, K. M., & Chodakewitz, J. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.59.062906.071602 · Cited by 82 · see citing works
In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa
Maphanga, T. G., Naicker, S. D., Kwenda, S., Muñoz, J. F., van Schalkwyk, E., Wadula, J., Nana, T., Ismail, A., Coetzee, J., Govind, C., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00517-21 · Cited by 78 · see citing works
Multiple roles of ABC transporters in yeast
Kumari, S., Kumar, M., Gaur, N. A., & Prasad, R. (2021) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2021.103550 · Cited by 66 · see citing works
Identification of the Putative Protein Phosphatase GenePTC1as a Virulence-Related Gene Using a Silkworm Model ofCandida albicansInfection
Hanaoka, N., Takano, Y., Shibuya, K., Fugo, H., Uehara, Y., & Niimi, M. (2008) · Eukaryotic Cell · doi:10.1128/ec.00129-08 · Cited by 67 · see citing works
MFS transporters of Candida species and their role in clinical drug resistance
Redhu, A. K., Shah, A. H., & Prasad, R. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow043 · Cited by 64 · see citing works
Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 64 · see citing works
ACandida albicansPetite Mutant Strain with Uncoupled Oxidative Phosphorylation OverexpressesMDR1and Has Diminished Susceptibility to Fluconazole and Voriconazole
Cheng, S., Clancy, C. J., Nguyen, K. T., Clapp, W., & Nguyen, M. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00182-07 · Cited by 62 · see citing works
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 54 · see citing works
Recent insights into the mechanisms of antifungal resistance
Barker, K. S., & Rogers, P. D. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0019-3 · Cited by 54 · see citing works
Fungal resistance to echinocandins and the MDR phenomenon in Candida glabrata
Healey, K., & Perlin, D. S. (2018) · doi:10.20944/preprints201808.0306.v1 · Cited by 194 · see citing works
Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review
Rabaan, A. A., Sulaiman, T., Al-Ahmed, S. H., Buhaliqah, Z. A., Buhaliqah, A. A., AlYuosof, B., Alfaresi, M. S., Fares, M. A. A., Alwarthan, S. M., Alkathlan, M. S., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12030608 · Cited by 53 · see citing works
Development of Antifungal Therapies Using Nanomaterials
Niemirowicz, K., Durnaś, B., Piktel, E., & Bucki, R. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0052 · Cited by 51 · see citing works
Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification
Perlin, D. S., & Wiederhold, N. P. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix121 · Cited by 50 · see citing works
Micafungin
Cross, S. A., & Scott, L. J. (2008) · Drugs · doi:10.2165/00003495-200868150-00010 · Cited by 45 · see citing works
Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors
Willers, C., Wentzel, J. F., Plessis, D., Gouws, C., & Hamman, J. H. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1265105 · Cited by 45 · see citing works
Voriconazole and multidrug resistance in Candida albicans
Wakieć, R., Prasad, R., Morschhäuser, J., Barchiesi, F., Borowski, E., & Milewski, S. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01327.x · Cited by 39 · see citing works
Gênero Candida - Fatores de virulência, Epidemiologia, Candidíase e Mecanismos de resistência
da Rocha, W. R. V., Nunes, L. E., Neves, M. L. D. R., Ximenes, E. A., & Albuquerque, M. C. P. D. A. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.14283 · Cited by 43 · see citing works
Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options
Amann, V., Kissmann, A., Firacative, C., & Rosenau, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040460 · Cited by 41 · see citing works
Targeting Candida spp. to develop antifungal agents
Salci, T. P., Negri, M., Abadio, A. K. R., Svidzinski, T. I. E., & Kioshima, É. S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.003 · Cited by 35 · see citing works
Transcriptome Signatures Predict Phenotypic Variations of Candida auris
Jenull, S., Tscherner, M., Kashko, N., Shivarathri, R., Stoiber, A., Chauhan, M., Petryshyn, A., Chauhan, N., & Kuchler, K. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.662563 · Cited by 32 · see citing works
Antifungal Activity against Candida Biofilms
Íñigo, M., Pemán, J., & del Pozo, J. L. (2012) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000170 · Cited by 32 · see citing works
Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis
Liu, X. P., Fan, S., Bai, F., Li, J., & Liao, Q. P. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01539.x · Cited by 30 · see citing works
Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells
Garcia-Rubio, R., Jimenez-Ortigosa, C., DeGregorio, L., Quinteros, C., Shor, E., & Perlin, D. S. (2021) · mBio · doi:10.1128/mbio.01959-21 · Cited by 29 · see citing works
Micafungin
Carter, N. J., & Keating, G. M. (2009) · Pediatric Drugs · doi:10.2165/00148581-200911040-00006 · Cited by 28 · see citing works
Fluconazole Transport into Candida albicans Secretory Vesicles by the Membrane Proteins Cdr1p, Cdr2p, and Mdr1p
Júnior, L. R. B., Gast, C. E., Mao, Y., & Wong, B. (2010) · Eukaryotic Cell · doi:10.1128/ec.00355-09 · Cited by 27 · see citing works
Cell Wall-Modifying Antifungal Drugs
Perlin, D. S. (2019) · Current topics in microbiology and immunology · doi:10.1007/82_2019_188 · Cited by 24 · see citing works
Micafungin activity against Candida albicans with diverse azole resistance phenotypes
Richards, T. S., Oliver, B. G. G., & White, T. C. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn156 · Cited by 25 · see citing works
Review on fungal enzyme inhibitors – potential drug targets to manage human fungal infections
Ramakrishnan, J., Rathore, S. S., & Raman, T. (2016) · RSC Advances · doi:10.1039/c6ra01577h · Cited by 27 · see citing works
Glutathione Metabolism in Candida albicans Resistant Strains to Fluconazole and Micafungin
Maras, B., Angiolella, L., Mignogna, G., Vavala, E., Macone, A., Colone, M., Pitari, G., Stringaro, A., Duprè, S., & Palamara, A. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098387 · Cited by 24 · see citing works
The correlation of virulence, pathogenicity, and itraconazole resistance with SAP activity in Candida albicans strains
Feng, W., Yang, J., Pan, Y., Xi, Z., Qiao, Z., & Ma, Y. (2015) · Canadian Journal of Microbiology · doi:10.1139/cjm-2015-0457 · Cited by 22 · see citing works
Identification and characterization ofCandida utilismultidrug efflux transporterCuCdr1p
Watanasrisin, W., Iwatani, S., Oura, T., Tomita, Y., Ikushima, S., Chindamporn, A., Niimi, M., Niimi, K., Lamping, E., Cannon, R. D., et al. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow042 · Cited by 20 · see citing works
Treatment of Invasive Candidiasis in Immunocompromised Pediatric Patients
Fisher, B. T., & Zaoutis, T. E. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810050-00003 · Cited by 20 · see citing works
Xenobiotic Efflux in Bacteria and Fungi: A Genomics Update
Barabote, R. D., Thekkiniath, J., Strauss, R. E., Vediyappan, G., Fralick, J. A., & Francisco, M. J. S. (2011) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470920541.ch6 · Cited by 20 · see citing works
Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression
Niimi, K., Woods, M. A., Maki, K., Nakayama, H., Hatakenaka, K., Chibana, H., Ikeda, F., Ueno, K., Niimi, M., Cannon, R. D., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks112 · Cited by 18 · see citing works
Candida glabrata: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen
Pfaller, M. A., Castanheira, M., Lockhart, S. R., & Jones, R. N. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0091-0 · Cited by 17 · see citing works
A Systematic Screen Reveals a Diverse Collection of Medications That Induce Antifungal Resistance in Candida Species
Butts, A., Reitler, P., Nishimoto, A. T., DeJarnette, C. A., Estredge, L. R., Peters, T. L., Veve, M. P., Rogers, P. D., & Palmer, G. E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00054-19 · Cited by 17 · see citing works
Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species
Nagayoshi, Y., Miyazaki, T., Shimamura, S., Nakayama, H., Minematsu, A., Yamauchi, S., Takazono, T., Nakamura, S., Yanagihara, K., Kohno, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180990 · Cited by 15 · see citing works
Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy
Amanati, A., Badiee, P., Jafarian, H., Ghasemi, F. S., Nematolahi, S., Haghpanah, S., & Hamzavi, S. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-93421-3 · Cited by 14 · see citing works
Lathyrol and epoxylathyrol derivatives: Modulation of Cdr1p and Mdr1p drug-efflux transporters of Candida albicans in Saccharomyces cerevisiae model
Mónico, A., Nim, S., Duarte, N., Rawal, M. K., Prasad, R., Pietro, A. D., & Ferreira, M. U. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.04.016 · Cited by 14 · see citing works
Creation, characterization and utilization of Cryptococcus neoformans mutants sensitive to micafungin
Toh‐e, A., Ohkusu, M., Shimizu, K., Yamaguchi, M., Ishiwada, N., Watanabe, A., & Kamei, K. (2017) · Current Genetics · doi:10.1007/s00294-017-0713-8 · Cited by 14 · see citing works
Characterization of caspofungin susceptibilities by broth and agar inCandidaalbicansclinical isolates with characterized mechanisms of azole resistance
Silver, P. M., Silver, P. M., Oliver, B. G. G., & White, T. C. (2008) · Medical Mycology · doi:10.1080/13693780701816557 · Cited by 14 · see citing works
Geranium leaf-mediated synthesis of silver nanoparticles and their transcriptomic effects on Candida albicans
Serrano-Díaz, P., Williams, D. W., Vega‐Arreguín, J., Manisekaran, R., Twigg, J. A., Morse, D. J., García‐Contreras, R., Arenas‐Arrocena, M. C., & Acosta‐Torres, L. S. (2023) · Green Processing and Synthesis · doi:10.1515/gps-2022-8105 · Cited by 13 · see citing works
Intracellular concentrations of micafungin in different cellular compartments of the peripheral blood
Farowski, F., Cornely, O. A., Vehreschild, J. J., Bauer, T., Hartmann, P., Steinbach, A., Vehreschild, M. J. G. T., Scheid, C., & Müller, C. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.11.006 · Cited by 13 · see citing works
Principles of a New Protocol for Prediction of Azole Resistance in Candida albicans Infections on the Basis of ERG11 Polymorphisms
Caban, M., Strapagiel, D., Dziadek, J., Korycka‐Machała, M., & Grzelak, A. (2016) · Current Microbiology · doi:10.1007/s00284-016-1039-3 · Cited by 13 · see citing works
Candidiasis asociada a biopelículas
del Pozo, J. L., & Cantón, E. (2015) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2015.06.004 · Cited by 19 · see citing works
Candida auris : host interactions, antifungal drug resistance, and diagnostics
Chowdhary, A., Lionakis, M. S., & Chauhan, N. (2025) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00187-22 · Cited by 13 · see citing works
Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
Akins, R. A., & Sobel, J. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_29 · Cited by 12 · see citing works
Ketorolac-fluconazole: A New Combination Reverting Resistance in Candida albicans from Acute Myeloid Leukemia Patients on Induction Chemotherapy: In vitro Study
Sayed, S. A., Hassan, E. A., Hameed, M. R. A., Agban, M. N., Saleh, M. F. M., Mohammed, H. H., Abdel‐Aal, A. M., & Elgendy, S. (2021) · Journal of Blood Medicine · doi:10.2147/jbm.s302158 · Cited by 11 · see citing works
Mechanisms of multidrug resistance caused by an Ipi1 mutation in the fungal pathogen Candida glabrata
Miyazaki, T., Shimamura, S., Nagayoshi, Y., Nakayama, H., Morita, A., Tanaka, Y., Matsumoto, Y., Inamine, T., Nishikawa, H., Nakada, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56269-z · Cited by 10 · see citing works
What ‘Omics can tell us about antifungal adaptation
Ribeiro, G. F., Denes, E., Heaney, H., & Childers, D. S. (2021) · FEMS Yeast Research · doi:10.1093/femsyr/foab070 · Cited by 9 · see citing works
A novel calcineurin-independent activity of cyclosporin A in Saccharomyces cerevisiae
Singh-Babak, S. D., Shekhar, T., Smith, A. M., Giaever, G. N., Nislow, C., & Cowen, L. E. (2012) · Molecular BioSystems · doi:10.1039/c2mb25107h · Cited by 9 · see citing works
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch130 · Cited by 7 · see citing works
Anidulafungin and its role in candida infections
Cappelletty, D. M. (2009) · Infection and Drug Resistance · doi:10.2147/idr.s4796 · Cited by 7 · see citing works
Inactivating the mannose-ethanolamine phosphotransferase Gpi7 confers caspofungin resistance in the human fungal pathogen Candida albicans
Zeng, G., Xu, X., Gao, J., Dantas, A. D. S., Gow, N. A. R., & Wang, Y. (2021) · The Cell Surface · doi:10.1016/j.tcsw.2021.100057 · Cited by 8 · see citing works
A study of genomic complexity underlying multidrug resistance in Candida auris strains in Thailand
Opassathian, K., Boonmee, N., Swangkaew, S., Jenjaroenpun, P., Wongsurawat, T., Kruasuwan, W., Ngamskulrungroj, P., & Mitrpant, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-25386-6 · Cited by 6 · see citing works

The Candida albicans Cdr2p ATP‐binding cassette (ABC) transporter confers resistance to caspofungin
Schuetzer‐Muehlbauer, M., Willinger, B., Krapf, G., Enzinger, S., Presterl, E., & Kuchler, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03430.x · Cited by 111 · see citing works
Micafungin activity against Candida albicans with diverse azole resistance phenotypes
Richards, T. S., Oliver, B. G. G., & White, T. C. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn156 · Cited by 25 · see citing works
Relative Contributions of the Candida albicans ABC Transporters Cdr1p and Cdr2p to Clinical Azole Resistance
Tsao, S., Rahkhoodaee, F., & Raymond, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00926-08 · Cited by 126 · see citing works
Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene
Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587 · see citing works
Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
Sanglard, D., Ischer, F., Monod, M., & Billé, J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2300 · Cited by 402 · see citing works

Authors: Niimi, K., Maki, K., Ikeda, F., Holmes, A. R., Lamping, E., Niimi, M., Monk, B. C., & Cannon, R. D.
Affiliations: University of Otago (NZ)
Astellas Pharma (Japan) (JP)
National Institute of Infectious Diseases (JP)
ORCID: Holmes, A. R.
Lamping, E.
Monk, B. C.
Cannon, R. D.
Venue: Antimicrobial Agents and Chemotherapy
Publisher: American Society for Microbiology
Published: 2006-04
Volume: 50
Issue: 4
Pages: 1148-1155
ISSN: 0066-4804 (ISSN-L)
1098-6596
DOI: 10.1128/aac.50.4.1148-1155.2006
PMC: PMC1426986
OpenAlex: W2120702660
Cited by: 134
References: 37
Citations by year: 2025: 7 · 2024: 2 · 2023: 6 · 2022: 2 · 2021: 10 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 14 · 2016: 10 · 2015: 8 · 2014: 5 · 2013: 4 · 2012: 9
FWCI: 7.54
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Antimicrobial Agents and Chemotherapy (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Japan Health Sciences Foundation
Astellas Pharma
Astellas Foundation for Research on Metabolic Disorders
National Institutes of Health
National Institute of Dental and Craniofacial Research (R21DE015075)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: Candida albicans, echinocandin susceptibility, micafungin, caspofungin, CDR1, CDR2, MDR1, ABC transporters, major facilitator superfamily, azole resistance, antifungal susceptibility testing, clinical isolates
MeSH terms: Caspofungin, Micafungin, Antifungal Agents, Candida albicans, Diffusion, Fungal Proteins, Lipoproteins, Microbial Sensitivity Tests, Peptides, Cyclic, ATP-Binding Cassette Transporters, Genes, MDR, Drug Resistance, Fungal, Membrane Transport Proteins, Echinocandins, Lipopeptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Overexpression of Candida albicans CDR1,CDR2, or MDR1 Does Not Produce Significant Changes in Echinocandin Susceptibility

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks